Terug
Ook genoteerd als
IVSXF
OTC
Dagbereik
€ 36,50
€ 36,74
52-Weeksbereik
€ 25,31
€ 41,85
Volume
300
50D / 200D Gem.
€ 38,85
/
€ 33,35
Vorige Slotkoers
€ 36,90
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Financial Services sector mediaan (857 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 0,7 | 10,2 |
| P/B | 0,1 | 1,1 |
| ROE % | 17,8 | 11,7 |
| Net Margin % | 71,0 | 16,8 |
| Rev Growth 5Y % | -4,5 | 11,7 |
| D/E | 0,1 | 0,5 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2028 |
€ 26,20
€ 25,47 – € 26,92
|
72,21B | 1 |
| FY2027 |
€ 25,56
€ 24,85 – € 26,27
|
69,40B | 1 |
| FY2026 |
€ 39,10
€ 38,02 – € 40,19
|
66,67B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-01-22 | N/A | € 1,96 | — |
| 2025-07-17 | N/A | € 1,54 | — |
| 2025-04-23 | N/A | -€ 0,10 | — |
| 2025-01-23 | N/A | -€ 0,93 | — |
| 2024-10-17 | N/A | € 0,40 | — |
| 2024-07-17 | N/A | € 2,01 | — |
| 2024-04-18 | N/A | € 2,02 | — |
| 2024-01-19 | N/A | € 1,94 | — |
Dividend History
7 yr streakYield
0,02%
Payout Ratio
0,10%
Growth (3Y)
10,81%
Growth (5Y)
-10,78%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Nov 09, 2026 | Nov 12, 2026 | € 0,17 | 1,63% |
| May 11, 2026 | May 15, 2026 | € 0,43 | 1,58% |
| Nov 10, 2025 | Nov 13, 2025 | € 0,15 | 1,63% |
| May 09, 2025 | May 14, 2025 | € 0,39 | 1,68% |
| Nov 11, 2024 | Nov 14, 2024 | € 0,11 | 1,62% |
| May 09, 2024 | May 15, 2024 | € 0,33 | 1,68% |
| Nov 03, 2023 | Nov 09, 2023 | € 0,10 | 2,33% |
| May 04, 2023 | May 10, 2023 | € 0,32 | 1,96% |
| Nov 04, 2022 | Nov 10, 2022 | € 0,09 | 2,48% |
| May 04, 2022 | May 10, 2022 | € 0,30 | 2,27% |
| Nov 05, 2021 | Nov 11, 2021 | € 0,12 | 1,69% |
| May 06, 2021 | May 12, 2021 | € 1,18 | 1,40% |
| Jun 18, 2020 | Jun 25, 2020 | € 0,95 | 2,59% |
| Nov 08, 2019 | Nov 14, 2019 | € 0,41 | 2,56% |
| May 09, 2019 | May 15, 2019 | € 0,93 | 3,09% |
| Nov 09, 2018 | Nov 15, 2018 | € 0,44 | 3,10% |
| May 09, 2018 | May 16, 2018 | € 0,92 | 2,16% |
| May 04, 2017 | May 10, 2017 | € 1,25 | 2,70% |
| May 11, 2016 | May 17, 2016 | € 1,23 | 3,66% |
| May 13, 2015 | May 20, 2015 | € 1,10 | 2,81% |
Belangrijkste Punten
Revenue declined -4,52% annually over 5 years
Earnings grew 38,96% over the past year
ROE of 17,77% — decent returns on equity
Net margin of 70,99% shows strong profitability
Debt/Equity of 0,12 — conservative balance sheet
Generating 18,99B in free cash flow
Groei
Revenue Growth (5Y)
-4,52%
Revenue (1Y)28,37%
Earnings (1Y)38,96%
FCF Growth (3Y)4,93%
Kwaliteit
Return on Equity
17,77%
ROIC11,28%
Net Margin70,99%
Op. Margin72,47%
Veiligheid
Debt / Equity
0,12
Current Ratio27,90
Interest Coverage34,35
Waardering
P/E Ratio
0,71
Forward P/E0,93
P/B Ratio0,12
EV/EBITDA1,28
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 28,37% | Revenue Growth (3Y) | 9,82% |
| Earnings Growth (1Y) | 38,96% | Earnings Growth (3Y) | 11,34% |
| Revenue Growth (5Y) | -4,52% | Earnings Growth (5Y) | -8,84% |
| Profitability | |||
| Revenue (TTM) | 221,86B | Net Income (TTM) | 157,49B |
| ROE | 17,77% | ROA | 14,28% |
| Gross Margin | 97,89% | Operating Margin | 72,47% |
| Net Margin | 70,99% | Free Cash Flow (TTM) | 18,99B |
| ROIC | 11,28% | FCF Growth (3Y) | 4,93% |
| Safety | |||
| Debt / Equity | 0,12 | Current Ratio | 27,90 |
| Interest Coverage | 34,35 | ||
| Dividends | |||
| Dividend Yield | 0,02% | Payout Ratio | 0,10% |
| Dividend Growth (3Y) | 10,81% | Dividend Growth (5Y) | -10,78% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 0,71 | Forward P/E | 0,93 |
| P/B Ratio | 0,12 | P/S Ratio | 0,50 |
| PEG Ratio | 0,16 | Forward PEG | N/A |
| EV/EBITDA | 1,28 | Fwd EV/EBITDA | 3,91 |
| Forward P/S | 1,68 | Fwd Earnings Yield | 107,53% |
| FCF Yield | 16,98% | ||
| Market Cap | 111,80B | Enterprise Value | 205,33B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 221,86B | 172,83B | 183,96B | -24,82B | 266,90B |
| Net Income | 157,49B | 113,34B | 127,05B | -74,68B | 228,07B |
| EPS (Diluted) | 51,39 | 37,01 | 41,46 | -24,38 | 74,41 |
| Gross Profit | 217,18B | 168,91B | 180,49B | -27,31B | 264,79B |
| Operating Income | 160,77B | 114,39B | 127,69B | -73,68B | 228,32B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,10T | 952,09B | 838,45B | 724,37B | 795,54B |
| Total Liabilities | 148,91B | 132,34B | 121,02B | 118,71B | 112,04B |
| Shareholders' Equity | 953,71B | 819,36B | 716,77B | 604,87B | 682,61B |
| Total Debt | 115,72B | 98,94B | 89,12B | 91,16B | 87,11B |
| Cash & Equivalents | 22,19B | 17,22B | 18,79B | 13,16B | 18,33B |
| Current Assets | 39,83B | 30,52B | 30,38B | 24,25B | 30,43B |
| Current Liabilities | 1,43B | 5,74B | 5,16B | 5,46B | 4,20B |
Strategiescores
This stock passed the criteria for 3 strategies
Score = fit strength (0–100)
Rank = position among all matches
Recente Activiteit
Uitgestapt
Contrarian Investing (David Dreman)
Mar 26, 2026
Uitgestapt
Defensive Investing (Benjamin Graham)
Mar 26, 2026
Ingestapt
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Ingestapt
Capital Light Compounder
Mar 24, 2026
Ingestapt
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Ingestapt
Contrarian Investing (David Dreman)
Mar 24, 2026
Ingestapt
Defensive Investing (Benjamin Graham)
Mar 24, 2026